KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Amortization of Deferred Charges (2020 - 2024)

Guardant Health (GH) has disclosed Amortization of Deferred Charges for 5 consecutive years, with $646000.0 as the latest value for Q4 2024.

  • Quarterly Amortization of Deferred Charges changed 0.31% to $646000.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $2.5 million through Dec 2024, down 1.62% year-over-year, with the annual reading at $2.6 million for FY2024, 0.23% changed from the prior year.
  • Amortization of Deferred Charges hit $646000.0 in Q4 2024 for Guardant Health, up from $600000.0 in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $4.7 million in Q4 2020 to a low of $600000.0 in Q2 2023.
  • Historically, Amortization of Deferred Charges has averaged $875588.2 across 5 years, with a median of $642000.0 in 2021.
  • Biggest five-year swings in Amortization of Deferred Charges: plummeted 86.42% in 2021 and later increased 0.31% in 2022.
  • Year by year, Amortization of Deferred Charges stood at $4.7 million in 2020, then tumbled by 86.42% to $642000.0 in 2021, then rose by 0.16% to $643000.0 in 2022, then grew by 0.16% to $644000.0 in 2023, then increased by 0.31% to $646000.0 in 2024.
  • Business Quant data shows Amortization of Deferred Charges for GH at $646000.0 in Q4 2024, $600000.0 in Q3 2024, and $600000.0 in Q2 2024.